Keiichi Akasaka Selected Research

Keiichi Akasaka Research Topics

Disease

8	Pulmonary Alveolar Proteinosis 05/2024 - 05/2012
5	Interstitial Lung Diseases (Interstitial Lung Disease) 04/2024 - 09/2010
5	Pneumonia (Pneumonitis) 12/2023 - 11/2016
4	Lung Neoplasms (Lung Cancer) 01/2020 - 08/2019
3	Idiopathic Pulmonary Fibrosis 11/2021 - 01/2017
2	Lung Diseases (Lung Disease) 04/2024 - 01/2017
2	Dermatomyositis (Dermatopolymyositis) 04/2024 - 04/2023
2	Systemic Scleroderma (Systemic Sclerosis) 04/2023 - 01/2017
2	Microscopic Polyangiitis 04/2023 - 11/2021
2	Fibrosis (Cirrhosis) 08/2021 - 05/2021
2	Carcinoma (Carcinomatosis) 01/2020 - 08/2019
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2019 - 09/2010
1	Body Weight Changes 04/2024
1	Weight Loss (Weight Reduction) 04/2024
1	Body Weight (Weight, Body) 04/2024
1	Respiratory Insufficiency (Respiratory Failure) 04/2024
1	Dermatitis 04/2024
1	COVID-19 12/2023
1	Viral Pneumonia 12/2023
1	VEXAS syndrome 08/2023
1	Rheumatoid Arthritis 04/2023
1	Bronchiectasis 11/2021
1	Hepatocellular Carcinoma (Hepatoma) 08/2021
1	Invasive Pulmonary Aspergillosis 08/2021
1	Ulcer 01/2021
1	Brain Neoplasms (Brain Tumor) 01/2020
1	Contact Dermatitis (Eczema, Contact) 01/2020
1	Exanthema (Rash) 01/2020
1	Neoplasms (Cancer) 01/2020
1	Lung Injury 01/2020
1	Deglutition Disorders (Dysphagia) 09/2019
1	Malnutrition (Nutritional Deficiencies) 09/2019
1	Aspiration Pneumonia 09/2019
1	Inflammation (Inflammations) 01/2018
1	Rare Diseases (Rare Disease) 08/2017
1	Atopic Dermatitis (Atopic Eczema) 01/2017
1	Asthma (Bronchial Asthma) 01/2017
1	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 11/2016
1	Disease Progression 11/2016
1	Infections 08/2015
1	Diarrhea 09/2010

Drug/Important Bio-Agent (IBA)

6	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2024 - 08/2015
5	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 04/2024 - 05/2012
4	Surface-Active Agents (Surfactants)IBA 05/2024 - 01/2015
4	Acetaminophen (Paracetamol)FDA LinkGeneric 04/2024 - 05/2012
2	CytokinesIBA 05/2024 - 01/2017
2	nintedanibIBA 04/2024 - 08/2019
2	SteroidsIBA 12/2023 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 09/2019 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 08/2017 - 01/2015
2	AutoantibodiesIBA 08/2017 - 05/2012
1	Indicators and Reagents (Reagents)IBA 04/2024
1	AntibodiesIBA 04/2024
1	Tacrolimus (Prograf)FDA LinkGeneric 04/2024
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2024
1	Lipoproteins (Lipoprotein)IBA 04/2024
1	Periodic AcidIBA 04/2024
1	sargramostim (Leukine)FDA Link 12/2023
1	EnzymesIBA 08/2023
1	Ligases (Synthetase)IBA 04/2023
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 11/2021
1	Peroxidase (Myeloperoxidase)IBA 11/2021
1	MacrolidesIBA 05/2021
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021
1	Ointments (Pastes)IBA 01/2020
1	Levetiracetam (Keppra)FDA LinkGeneric 01/2020
1	NivolumabIBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	Hypnotics and Sedatives (Sedatives)IBA 09/2019
1	titanium silicide (TS-1)IBA 08/2019
1	pembrolizumabIBA 08/2019
1	Tyrosine Kinase InhibitorsIBA 08/2019
1	Antifibrotic AgentsIBA 08/2019
1	Immune Checkpoint InhibitorsIBA 08/2019
1	atezolizumabIBA 08/2019
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018
1	PeriostinIBA 01/2017
1	Sirolimus (Rapamycin)FDA Link 11/2016
1	lipoarabinomannan (LAM)IBA 11/2016
1	Immunoglobulin G (IgG)IBA 05/2012
1	Immunoglobulin M (IgM)IBA 05/2012
1	Gefitinib (Iressa)FDA Link 09/2010

Therapy/Procedure

7	Therapeutics 04/2024 - 01/2015
2	Drug Therapy (Chemotherapy) 09/2019 - 08/2019
1	Aftercare (After-Treatment) 04/2024
1	Traction 11/2021
1	Oral Hygiene (Dental Hygiene) 09/2019
1	Retreatment 08/2019